Managing patients with antipsychotic drug-induced hyperprolactinaemia.
This article outlines a range of interventions that mental health nurses can use in the management of patients with hyperprolactinaemia induced by antipsychotic medication. The article is aimed primarily at mental health nurse prescribers, but is relevant to all mental health nurses to inform their care of people at risk of developing an elevated prolactin level.
Jones
Adrian
A
Adult Mental Health, Wrexham Maelor Hospital, North East Wales NHS Trust, Wrexham. adrian.jones@new-tr.wales.nhs.uk
Jones
Martin
M
D014150:Antipsychotic Agents / Q000009:adverse effects*; D016903:Drug Monitoring / Q000379:methods / Q000451:nursing; D011307:Drug Prescriptions / Q000451:nursing; D006801:Humans; D006966:Hyperprolactinemia / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*; D008487:Medical History Taking; D024802:Nurse's Role; D009730:Nursing Assessment; D018579:Patient Selection; D017009:Professional Autonomy; D011568:Psychiatric Nursing / Q000379:methods*; D012559:Schizophrenia / Q000188:drug therapy / Q000209:etiology
D014150:Antipsychotic Agents